Announcements Trials
Browse Landscape

Phase

Phase NA 14Phase 4 2Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 70Gastrointestinal 8Head & Neck 6Gynecologic 6Genitourinary 5Dermatologic 5Lymphoid 3CNS 3Breast 3Other hematologic neoplasm 2Other 2Sarcoma 1NET 1Endocrine 1Classical hematology 1

Conditions

Obesity 23Polycystic Ovary Syndrome 13Overweight 6Sexual Dysfunction, Physiological 5Neoplasms 5Mucositis 5Constipation 5Opioid-Induced Constipation 4Multiple Endocrine Neoplasia Type 1 3Inflammation 3Head and Neck Neoplasms 3Pain 2Nausea 2Lung Neoplasms 2Infertility 2Diabetes, Gestational 2Cancer-related Fatigue 2Cancer Pain 2Breast Neoplasms 2Xerostomia 1Weight Loss 1Vomiting 1Uterine Cervical Neoplasms 1Stomatitis 1Stomach Ulcer 1Stomach Neoplasms 1Rectal Neoplasms 1Radiation-induced Oral Mucositis 1Prostatic Neoplasms 1Pregnancy Complications 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × Other × Clear all
NCT00338481 2011-07-27

"Red Morphine Drops" for Symptomatic Treatment of Dyspnoea in Lung Cancer

Sankt Lukas Hospice

Phase 4 Completed
20 enrolled
OtherThoracic

Dyspnea, Lung Neoplasms

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Mt. Sinai Medical Center, Miami

Phase 4 Completed
452 enrolled
Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡